Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Alkylator-Intense Conditioning Followed by Autologous Transplantation for Patients With High Risk or Relapsed Solid or CNS Tumors

NCT01505569 is registered in ClinicalTrials.gov with Masonic Cancer Center, University of Minnesota as lead sponsor.

NCT NCT01505569
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01505569 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Alkylator-Intense Conditioning Followed by Autologous Transplantation for Patients With High Risk or Relapsed Solid or CNS Tumors
Lead sponsor
Masonic Cancer Center, University of Minnesota
Phase
Not applicable
Overall status
Completed
Start date
October 20, 2011
Completion date
February 1, 2024
Enrollment
44 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atypical teratoid/rhabdoid tumor (at/rt), cns tumors, ewing's family tumors, germ cell tumors, hepatoblastoma, medulloblastoma, primary malignant brain neoplasms, renal tumors, retinoblastoma, rhabdomyosarcoma, soft tissue sarcoma, supra-tentorial primative neuro-ectodermal tumor (pnet)